analyst reports

With a $2 billion valuation, Tilray Brands (NASDAQ: TLRY) ranks as the largest cannabis company outside the U.S., leading in international sales and the Canadian recreational market. Pablo Zuanic of Zuanic & Associates has initiated coverage on Tilray with a 'Neutral' rating,...

Benzinga recently reviewed the balance sheet and cash flow trends of Canadian LPs (licensed producers). Zuanic & Associates presents crucial factual key findings: StatCan (official government source) reported May cannabis retail sales (rec) of $415.6Mn, up 1.2% MoM, and -2.1% in day-adjusted...

The percentage of cannabis acceptors in the U.S. who support legalization but do not consume it has decreased in recent years, according to a new report by BDSA. The research and analytics firm found that a polarized society and a growing number of legalization supporters explain the...

With the second quarter coming to an end for the U.S. economy, there has been a noticeable decrease in interest rates, as the ten-year treasury yield fell to 2.833% on Tuesday. Slowing Growth: The S&P 500 equity risk premium has risen to 340bp, while the fair value level is estimated...

Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ: TLRY) Aug qtr sales estimates in his Thursday note. The Analyst: Zuanic kept an “Overweight” rating on Tilray but tweaks the 12-month price target to US$18 from US$19 on lower sales estimates. The...